The outbreak of the pandemic associated with Severe Acute Respiratory Syndrome
coronavirus 2 (SARS-CoV-2) led researchers to find new potential treatments, including …

The main basis for hydroxychloroquine (HCQ) treatment in COVID‐19 is the compound's
ability to inhibit viral replication in vitro. HCQ also suppresses immunity, mainly by …

The COVID-19 pandemic, caused by SARS-CoV-2–a novel and highly infectious
coronavirus, has been spreading around the world for over a year, and poses a serious …

Chloroquine and hydroxychloroquine impair in vitro the terminal glycosylation of angiotensin-
converting enzyme 2 (ACE-2), which is known to be cardioprotective. As these …

Background: Many of the known coronaviruses cause a wide range of respiratory infections
in humans, and the novel coronavirus is no exception to this rule. Although no drug has yet …

Introduction. As the COVID-19 pandemic continues to pose a significant challenge to global
health, effective therapeutic options for preventing and treating the disease have become …

Objective In the last two years progress was made in molecular, physio pathological
understanding and the form of transmission of COVID-19, and different therapeutic …

Introduction: Coronavirus pandemic is currently a global health concern with no established
treatment guidelines. The aim of the present study was to determine the therapeutic …

Objective: The admission rates to intensive care units and mortalities in geriatric patients are
higher than the rest of the population with COVID-19 infection. Although the efficacy of …

Objective: The admission rates to intensive care units and mortalities in geriatric patients are
higher than the rest of the population with COVID-19 infection. Although the efficacy of …